RECRUITING

Reducing Urban Cervical Cancer Disparities

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Official Title

Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance

Quick Facts

Study Start:2024-08-28
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06416150

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
  2. * referral for colposcopic evaluation at the clinic sites,
  3. * able to communicate with ease in English,
  4. * have a cell phone with texting ability, and
  5. * competent to give consent.
  1. * are pregnant at the time of recruitment,
  2. * display current evidence or have a history of positive invasive carcinoma of the cervix, or
  3. * require follow-up but not a colposcopy.

Contacts and Locations

Study Contact

Suzanne M Miller, PhD
CONTACT
215-728-4069
suzanne.miller@fccc.edu
Erin K Tagai, PhD, MPH
CONTACT
215-728-5621
erin.tagai@fccc.edu

Principal Investigator

Suzanne M Miller, PhD
PRINCIPAL_INVESTIGATOR
Fox Chase Cancer Center

Study Locations (Sites)

Rutgers, The State University of New Jersey
New Brunswick, New Jersey, 08901
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107
United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111
United States

Collaborators and Investigators

Sponsor: Fox Chase Cancer Center

  • Suzanne M Miller, PhD, PRINCIPAL_INVESTIGATOR, Fox Chase Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-28
Study Completion Date2027-12

Study Record Updates

Study Start Date2024-08-28
Study Completion Date2027-12

Terms related to this study

Additional Relevant MeSH Terms

  • Cervical Cancer
  • Papilloma Viral Infection